Trial intelligence / Profile preview

Heliox versus oxygen-air during weaning from mechanical ventilation

2005-003612-30Phase 4Completed

Sponsor
Barts Health NHS Trust
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of heliox21 in respiratory failure and critical illness (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: CO2 production. Started Oct 2005; status: completed.

02

Drugs

heliox21
03

Conditions

respiratory failurecritical illness

Beyond the preview

Go deeper on 2005-003612-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003612-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call